SkinBioTherapeutics (GB:SBTX) has released an update.
SkinBioTherapeutics PLC announces positive final testing results of its SkinBiotix technology by Croda Beauty Care, confirming efficacy and paving the way for commercialization with new marketing and technical updates planned. The company is in the process of finalizing additional commercial terms and preparing for a formal product launch at In-Cosmetics Global in 2025. Investors are advised to watch for updates on this partnership, which promises tiered royalties from future global sales in the cosmetics sector.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
